행사/교육
제17차 대한암학회 추계학술대회
- 등록일2012-10-25
- 조회수4030
- 구분 국내
- 행사교육분류 행사
-
주관기관
대한암학회
-
행사장소
서울롯데호텔(소공동) 2층 크리스탈볼룸
-
행사기간
2012-11-16
- 원문링크
-
첨부파일
제17차 대한암학회 추계학술대회
* 등록비 : 회원 5만원, 비회원 6만원
* 사전등록마감 : 10월 31일까지 (이후는 현장등록만 가능)
* 등록방법 : 대한암학회 홈페이지
* 문 의 처 : 02-792-1486
[Plenary Lecture]
11:00~12:00, Hall A~C
Understanding KRAS; Its Effects on Patient Response and the Search for Inhibitors
Garth Powis, M.D., Ph.D.
Chair, Experimental Therapeutics
The University of Texas MD Anderson Cancer Center, USA
[Symposium]
1. Targeting Cancer Stem Cells
09:00~10:40, Hall A
1) Personalized Therapeutic Approaches Based on Cancer Stem Cell Biology
남도현 (성균관의대)
2) Targeting Ras Addition to Eradicate Cancer Stem Cells
이수재 (한양대학교)
3) Mesenchymal Stem-like Cells in Glioma Microenvironment: Possible New Target Cells as a Helper of Glioma Cancer Stem Cells
강석구 (연세의대)
4) Combinatorial Targeting of Cancer Stem Cells with Stemness Inhibitors and Diffentiation Inducer
김형기 (고려대학교)
2. Practical Issues and Research Questions in Neoadjuvant Therapy
09:00~10:40, Hall C
1) Head and Neck Cancer
박건욱 (계명의대)
2) Breast Cancer
김성배 (울산의대)
3) Gastric Cancer
김태용 (서울의대)
4) Prediction of Response to Preoperative Chemoradiation for Locally Advanced Rectal Cancer
김대용 (국립암센터)
3. Mechanisms of Anticancer Drug Resistance : Rational Design For Cancer Therapy
13:20~15:00, Hall A
1) Phosphorylation of rpS3 and TRAF2 Mediates Radioresistance in Non-small Cell Lung Cancer Cells
윤부현 (부산대학교)
2) HER2 Directed Therapy Beyond Trastuzumab
임석아 (서울의대)
3) How to Overcome Tumor Heterogeneity: Targeting Tumor Vasculature and Apoptosis
김인산 (경북의대)
4) Tumor Metastasis Marker UCH-L1 and its Regulation
이공주 (이화여자대학교)
4. Design Issues in Clinical Trials: Selection of Endpoints
13:20~15:00, Hall C
1) Recent Trends of Endpoints in Cancer Clinical Trials: General Overview
이기형 (충북의대)
2) Patient Reported Outcome
윤영호 (서울의대)
3) Comparative Effectiveness Research
윤환중 (충남의대)
4) Endpoints in Early Phase Cancer Clinical Trials with Targeted Agents
박숙련 (국립암센터)
5. Clinical Application of Personalized Genomics
15:20~17:00, Hall A
1) Understanding Disease Susceptibility Through Population Genomics
김상수 (숭실대학교)
2) AMPKα Modulation in Cancer Progression: Multi-layer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer
김연희 (국립암센터)
3) Whole Transcriptome and Genome Sequencing of Lung and Liver Cancer Patients
Dr. Zemin Zhang (Genetech Inc.)
6. EGFR-targeted Therapy: How Far has it come?
15:20~17:00, Hall C
1) Current Status of EGFR-TKIs in Advanced Non-small Cell Lung Cancer
한지연 (국립암센터)
2) Therapeutic Targeting of the EGFR Signaling in Non-small Cell Lung Cancer: Opportunities, Challenges and Limitations
조병철 (연세의대)
3) Current Regimen and Unmet Need in Breast Cancer ; Potential Niche Area of EGFR-targeted Antibody in TNBC
이정언 (성균관의대)
4) EGFR-targeted Antibody Therapeutics in Colorectal Cancer
원종화 (목암생명공학연구소)
[International Cancer Genome Conference 2012]
09:00~17:00, Hall B
Seishi Ogawa, MD, PhD (University of Tokyo, Japan)
Meredith Yeager, PhD (NCI, USA)
Mark Minden, MD, PhD (University Health Network, Canada)
Teh Bin Tean, MD, PhD (Van Andel Institute, Singapore)
Wang Jun, MD, PhD (BGI, China)
Tatsuhiro Shibata, MD, PhD (National Cancer Center Research Institute, Japan)
Daehyun Baek, PhD (Seoul National University, Korea)
Sungmin An, MD, PhD (Gacheon Medical School, Korea)
Yeun Jun Chung, MD, PhD (The Catholic University of Korea School of Medicine, Korea)
[Luncheon Symposium]
12:00~13:00, Hall A~C
Targeting the Hedgehog Pathway in Cancer: From Bench to Clinic
Frédéric J. de Sauvage (Vice President-Research Molecular Biology, Genentech Inc.)